Mar 30, 2026 4:05pm EDT RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update
Mar 26, 2026 8:30am EDT RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment
